In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Celdara Medical LLC

Latest From Celdara Medical LLC

Celyad Signs Deal With Japan's Ono For CAR-T-Like Program

Celyad has struck a deal with Ono Pharmaceutical for certain rights to its allogeneic NKR-2 T-cell immunotherapy, a variation on traditional CAR-T approaches. The agreement eases some of the pressure from the recent late stage failure of Celyad's heart failure cell therapy.

BioPharmaceutical Commercial

Deals Shaping The Medical Industry, February 2015

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, Pharmaceuticals, and Research/Analytical – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced December 2014-January 2015.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Cardiovascular
  • Dermatology
  • Infectious & Viral Diseases
  • Inflammation
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Celdara Medical LLC
  • Senior Management
  • Jake Reder, CEO
    Michael W Fanger, PhD, CSO
  • Contact Info
  • Celdara Medical LLC
    Phone: (617) 320-8521
    16 Cavendish Ct. DRTC
    Lebanon, NH 03766